(Q37909299)

25 August 2017

1 reference

title

Bispecific antibody: a tool for diagnosis and treatment of disease (English)

1 reference

25 August 2017

1 reference

Songsivilai S

1

1 reference

PubMed ID

2180597

25 August 2017

Lachmann PJ

series ordinal

2

1 reference

PubMed ID

2180597

25 August 2017

language of work or name

1 reference

1 March 1990

1 reference

Clinical and Experimental Immunology

25 August 2017

1 reference

25 August 2017

79

1 reference

25 August 2017

315-321

1 reference

25 August 2017

3

1 reference

A novel strategy for producing chimeric bispecific antibodies by gene transfection

25 August 2017

1 reference

12 December 2020

Targeted cancer treatment.

1 reference

12 December 2020

Hybrid hybridoma producing a bispecific monoclonal antibody that can focus effector T-cell activity

1 reference

12 December 2020

Preparation and biomedical applications of bispecific antibodies

1 reference

12 December 2020

Replacing the complementarity-determining regions in a human antibody with those from a mouse

1 reference

12 December 2020

Activation of human peripheral blood mononuclear cells by anti-T3: killing of tumor target cells coated with anti-target-anti-T3 conjugates

1 reference

12 December 2020

Cyclic tetramolecular complexes of monoclonal antibodies: a new type of cross-linking reagent

1 reference

12 December 2020

Bispecific monoclonal antibodies from hybrid hybridomas

1 reference

12 December 2020

Advantages of bispecific hybridomas in one-step immunocytochemistry and immunoassays

1 reference

12 December 2020

Hybrid antibody-mediated lysis of virus-infected cells

1 reference

12 December 2020

Binding and cytotoxic effect of ricin toxin on multivalent hybrid antibody-coated target cells

1 reference

12 December 2020

Bi-specific monoclonal antibodies: selective binding and complement fixation to cells that express two different surface antigens

1 reference

12 December 2020

Lysis of tumor cells by the retargeting of murine cytolytic T lymphocytes with bispecific antibodies

1 reference

12 December 2020

Preparation and performance of bispecific F(ab' gamma)2 antibody containing thioether-linked Fab' gamma fragments

1 reference

12 December 2020

IgA:IgM and IgA:IgA hybrid hybridomas secrete heteropolymeric immunoglobulins that are polyvalent and bispecific

1 reference

12 December 2020

T-cell killing of target cells induced by hybrid antibodies: comparison of two bispecific monoclonal antibodies

1 reference

12 December 2020

Enhanced antiproliferative action of interferon targeted by bispecific monoclonal antibodies

1 reference

12 December 2020

Enrichment and Selection of Hybrid Hybridomas by Percoll Density Gradient Centrifugation and Fluorescent-Activated Cell Sorting

1 reference

12 December 2020

Recombination of a mixture of univalent antibody fragments of different specificity

1 reference

12 December 2020

A human hybrid hybridoma.

1 reference

12 December 2020

Luminescent detection method for immunodot, Western, and Southern blots

1 reference

12 December 2020

Heteroantibody-mediated cytotoxicity: antibody to the high affinity Fc receptor for IgG mediates cytotoxicity by human monocytes that is enhanced by interferon-gamma and is not blocked by human IgG

1 reference

12 December 2020

Bispecific antibody-producing hybrid hybridomas selected by a fluorescence activated cell sorter

1 reference

12 December 2020

The use of hybrid hybridomas to target human cytotoxic T lymphocytes.

1 reference

12 December 2020

Construction and characterisation of a hybrid-hybrid monoclonal antibody recognising both carcinoembryonic antigen (CEA) and vinca alkaloids.

1 reference

12 December 2020

Specific in vitro and in vivo drug localisation to tumour cells using a hybrid-hybrid monoclonal antibody recognising both carcinoembryonic antigen (CEA) and vinca alkaloids

1 reference

12 December 2020

Targeting cytotoxic T cells to antigen-specific B lymphocytes

1 reference

12 December 2020

Noncovalent interaction between immunoglobulin (Ig) polypeptide chains. II. Absence of hybrid molecule formation between Ig Classes

1 reference

12 December 2020

Fusion of Two Immunoglobulin-producing Myeloma Cells

1 reference

12 December 2020

Pattern of immunoglobulin synthesis and assembly in a human-mouse somatic cell hybrid clone

1 reference

12 December 2020

The covalent binding of daunomycin and adriamycin to antibodies, with retention of both drug and antibody activities

1 reference

12 December 2020

Continuous cultures of fused cells secreting antibody of predefined specificity

1 reference

12 December 2020

Antigenic modulation of lymphocytic surface immunoglobulin yielding resistance to complement-mediated lysis. II. Relationship to redistribution of the antigen.

1 reference

12 December 2020

Antigenic modulation of lymphocytic surface immunoglobulin yielding resistance to complement-mediated lysis. I. Characterization with syngeneic and xenogeneic complements

1 reference

12 December 2020

Hybrid antibodies with dual specificity for the delivery of ricin to immunoglobulin-bearing target cells

1 reference

12 December 2020

Hybrid hybridomas and their use in immunohistochemistry

1 reference

12 December 2020

Therapeutic potential of monovalent monoclonal antibodies

1 reference

12 December 2020

Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains

1 reference

12 December 2020

Production of functional chimaeric mouse/human antibody

1 reference

12 December 2020

Production of target-specific effector cells using hetero-cross-linked aggregates containing anti-target cell and anti-Fc gamma receptor antibodies

1 reference

12 December 2020

A hapten-specific chimaeric IgE antibody with human physiological effector function.

1 reference

12 December 2020

Hybrid antibodies can target sites for attack by T cells

1 reference

12 December 2020

Preparation of bispecific antibodies by chemical recombination of monoclonal immunoglobulin G1 fragments

1 reference

12 December 2020

Evidence for a novel hybrid immunotoxin recognizing ricin A-chain by one antigen-combining site and a prostate-restricted antigen by the remaining antigen-combining site: potential for immunotherapy

1 reference

12 December 2020

Specific targeting of cytotoxic T cells by anti-T3 linked to anti-target cell antibody

1 reference

12 December 2020

In vivo detection of human hepatoma secreting hepatitis B surface antigen in nude mice with radiolabeled monoclonal antibodies that recognize distinct epitopes

1 reference

12 December 2020

Heteroantibody duplexes target cells for lysis by cytotoxic T lymphocytes

1 reference

12 December 2020

Targeting of cancer with radiolabeled antibodies. Prospects for imaging and therapy.

1 reference

12 December 2020

Production and ELISA application of bispecific monoclonal antibodies against fluorescein isothiocyanate (FITC) and horseradish peroxidase (HRP).

1 reference

12 December 2020

Cytolysis by cloned helper T cells: induction by specific antigen or by anti-CD3 hybrid antibodies

1 reference

12 December 2020

Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli

1 reference

12 December 2020

Production of murine hybrid-hybridomas secreting bispecific monoclonal antibodies for use in urease-based immunoassays.

1 reference

12 December 2020

Universal bispecific antibody for targeting tumor cells for destruction by cytotoxic T cells

1 reference

12 December 2020

Single-chain antigen-binding proteins

1 reference

12 December 2020

Bispecific F(ab' gamma)2 antibody for the delivery of saporin in the treatment of lymphoma

1 reference

12 December 2020

Antibody-directed fibrinolysis. An antibody specific for both fibrin and tissue plasminogen activator.

1 reference

12 December 2020

A simple metabolic system for selection of hybrid hybridomas (tetradomas) producing bispecific monoclonal antibodies.

1 reference

12 December 2020

Production of hybrid hybridomas based on HAT(s)-neomycin(r) double mutants

1 reference

12 December 2020

Antibody toxin conjugates: a perspective

1 reference

12 December 2020

Induction of tumor-cell lysis by bi-specific monoclonal antibodies recognizing renal-cell carcinoma and CD3 antigen

1 reference

12 December 2020

Induction of lysis by T cell receptor gamma delta+/CD3+ T lymphocytes via CD2 requires triggering via the T11.1 epitope only

1 reference

12 December 2020

Bispecific antibody-producing hybrid hybridoma and its use in one-step immunoassays for human lymphotoxin

1 reference

12 December 2020

Morphological characterization of substance P-like immunoreactive glomeruli in the superficial dorsal horn of the rat spinal cord and trigeminal subnucleus caudalis: a quantitative study

1 reference

12 December 2020

Triggering T cells by otherwise inert hybrid anti-CD3/antitumor antibodies requires encounter with the specific target cell

1 reference

12 December 2020

Rationale for immunotoxin therapy of metastatic prostate carcinoma formatted as a multi-stage delivery system.

1 reference

12 December 2020

Binding activities of a repertoire of single immunoglobulin variable domains secreted from Escherichia coli

1 reference

12 December 2020

10.1111/J.1365-2249.1990.TB08089.X

Identifiers

DOI

1 reference

25 August 2017

0 references

1 reference

PubMed ID

2180597